Ruth B Murray
Overview
Explore the profile of Ruth B Murray including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
343
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Porsbjerg C, Townend J, Bergeron C, Christoff G, Katsoulotos G, Larenas-Linnemann D, et al.
Front Immunol
. 2024 May;
15:1361891.
PMID: 38711495
Background: To date, studies investigating the association between pre-biologic biomarker levels and post-biologic outcomes have been limited to single biomarkers and assessment of biologic efficacy from structured clinical trials. Aim:...
2.
Chen W, Tran T, Sadatsafavi M, Murray R, Boon Wong N, Ali N, et al.
J Allergy Clin Immunol Pract
. 2024 Feb;
12(2):536-539.
PMID: 38336403
No abstract available.
3.
Wechsler M, Scelo G, Larenas-Linnemann D, Torres-Duque C, Maspero J, Tran T, et al.
Am J Respir Crit Care Med
. 2023 Nov;
209(3):262-272.
PMID: 38016003
Previous studies investigating the impact of comorbidities on the effectiveness of biologic agents have been relatively small and of short duration and have not compared classes of biologic agents. To...
4.
Chen W, Sadatsafavi M, Tran T, Murray R, Wong C, Ali N, et al.
J Asthma Allergy
. 2022 Oct;
15:1491-1510.
PMID: 36303891
Background: Many severe asthma patients with high oral corticosteroid exposure (HOCS) often do not initiate biologics despite being eligible. This study aimed to compare the characteristics of severe asthma patients...
5.
6.
Menzies-Gow A, McBrien C, Unni B, Porsbjerg C, Al-Ahmad M, Ambrose C, et al.
J Asthma Allergy
. 2022 Jan;
15:63-78.
PMID: 35046670
Introduction: International registries provide opportunities to describe use of biologics for treating severe asthma in current clinical practice. Our aims were to describe real-life global patterns of biologic use (continuation,...
7.
Porsbjerg C, Menzies-Gow A, Tran T, Murray R, Unni B, Audrey Ang S, et al.
J Allergy Clin Immunol Pract
. 2022 Jan;
10(5):1202-1216.e23.
PMID: 34990866
Background: Regulatory bodies have approved five biologics for severe asthma. However, regional differences in accessibility may limit the global potential for personalized medicine. Objective: To compare global differences in ease...
8.
Kerkhof M, Tran T, Allehebi R, Canonica G, Heaney L, Hew M, et al.
J Allergy Clin Immunol Pract
. 2021 Aug;
9(12):4353-4370.
PMID: 34403837
Background: We developed an eosinophil phenotype gradient algorithm and applied it to a large severe asthma cohort (International Severe Asthma Registry). Objective: We sought to reapply this algorithm in a...
9.
Heaney L, Perez de Llano L, Al-Ahmad M, Backer V, Busby J, Canonica G, et al.
Chest
. 2021 Apr;
160(3):814-830.
PMID: 33887242
Background: Phenotypic characteristics of patients with eosinophilic and noneosinophilic asthma are not well characterized in global, real-life severe asthma cohorts. Research Question: What is the prevalence of eosinophilic and noneosinophilic...
10.
Denton E, Price D, Tran T, Canonica G, Menzies-Gow A, FitzGerald J, et al.
J Allergy Clin Immunol Pract
. 2021 Mar;
9(7):2680-2688.e7.
PMID: 33744476
Background: Allergy, eosinophilic inflammation, and epithelial dysregulation are implicated in severe asthma pathogenesis. Objective: We characterized biomarker expression in adults with severe asthma. Methods: Within the International Severe Asthma Registry...